ArticleBritish journal of cancer2005

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.

J-L Fischel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.